
Photo from Andrea Morandi/Linkedin
Jun 29, 2024, 23:21
Andrea Morandi: A critical vulnerability in triple-negative breast cancer
Andrea Morandi, Professor at University of Florence, shared on LinkedIn:
“I’m thrilled to share our latest research out in EMBO Molecular Medicine uncovering a critical vulnerability in triple-negative breast cancer. This discovery opens new avenues for innovative treatments by targeting specific enzymes and leveraging ferroptosis.”
Source: Andrea Morandi/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 15:10
Apr 15, 2025, 14:40
Apr 15, 2025, 14:12